Back to Search
Start Over
PDE4B Proposed as a High Myopia Susceptibility Gene in Chinese Population.
- Source :
-
Frontiers in genetics [Front Genet] 2022 Jan 12; Vol. 12, pp. 775797. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2021). - Publication Year :
- 2022
-
Abstract
- Myopia is the most common cause of refractive error worldwide. High myopia is a severe type of myopia, which usually accompanies pathological changes in the fundus. To identify high myopia susceptibility genes, DNA-pooling based genome-wide association analysis was used to search for a correlation between single nucleotide polymorphisms and high myopia in a Han Chinese cohort (cases vs. controls in discovery stage: 507 vs. 294; replication stage 1: 991 vs. 1,025; replication stage 2: 1,021 vs. 52,708). Three variants (rs10889602T/G, rs2193015T/C, rs9676191A/C) were identified as being significantly associated with high myopia in the discovery, and replication stage. rs10889602T/G is located at the third intron of phosphodiesterase 4B ( PDE4B ), whose functional assays were performed by comparing the effects of rs10889602T/T deletion of this risk allele on PDE4B and COL1A1 gene and protein expression levels in the rs10889602T/T <superscript>del/del</superscript> , rs10889602T/T <superscript>del/wt</superscript> , and normal control A549 cell lines. The declines in the PDE4B and COL1A1 gene expression levels were larger in the rs10889602T/T deleted A549 cells than in the normal control A549 cells (one-way ANOVA, p < 0.001). The knockdown of PDE4B by siRNA in human scleral fibroblasts led to downregulation of COL1A1. This correspondence between the declines in rs10889602 of the PDE4B gene, PDE4B knockdown, and COL1A1 protein expression levels suggest that PDE4B may be a novel high myopia susceptibility gene, which regulates myopia progression through controlling scleral collagen I expression levels. More studies are needed to determine if there is a correlation between PDE4B and high myopia in other larger sample sized cohorts.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Zhao, Chen, Zhou, Reinach, Wang, Juo, Yang, Xue, Shi, Liang, Zeng, Qu and Zhou.)
Details
- Language :
- English
- ISSN :
- 1664-8021
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in genetics
- Publication Type :
- Academic Journal
- Accession number :
- 35116054
- Full Text :
- https://doi.org/10.3389/fgene.2021.775797